trending Market Intelligence /marketintelligence/en/news-insights/trending/xGdiyWojFYd_IEd4_TcRAA2 content esgSubNav
In This List

Cadila granted US FDA approval to market antidepressant

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Cadila granted US FDA approval to market antidepressant

The U.S. Food and Drug Administration granted Cadila Healthcare Ltd. approval to market a generic version of an antidepressant drug.

The Indian pharmaceutical company will market mirtazapine in three doses, which will be produced at its manufacturing facility in Baddi, India.